DR. REDDY'S LABORATORIES-ADR (RDY) Stock Earnings Estimates
NYSE:RDY • US2561352038
14.705 USD
+0.01 (+0.03%)
Last: Feb 24, 2026, 03:15 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 246.697B 14.50% | 280.111B 13.54% | 326.439B 16.54% | 349.965B 7.21% | 360.321B 2.96% | 394.332B 9.44% | 414.582B 5.14% | 446.476B 7.69% | |
| EBITDA YoY % growth | 65.4B 39.21% | 79.334B 21.31% | 87.164B 9.87% | 83.624B -4.06% | 79.117B -5.39% | 88.286B 11.59% | 104.457B 18.32% | 113.384B 8.55% | |
| EBIT YoY % growth | 52.898B 49.73% | 64.634B 22.19% | 70.127B 8.50% | 63.903B -8.88% | 58.391B -8.63% | 66.894B 14.56% | 82.459B 23.27% | 92.125B 11.72% | |
| Operating Margin | 21.44% | 23.07% | 21.48% | 18.26% | 16.21% | 16.96% | 19.89% | 20.63% | |
| EPS YoY % growth | 54.23 90.38% | 66.94 23.45% | 67.84 1.35% | 63.54 -6.34% | 57.19 -9.99% | 65.00 13.65% | N/A | N/A |
All data in INR
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 13.38 -30.02% | 15.23 -10.59% | 15.89 -1.78% | 17.22 18.51% | 17.89 33.70% |
| Revenue Q2Q % growth | 87.118B 2.15% | 92.669B 8.11% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 17.561B -47.80% | 23.167B -2.02% | N/A | N/A | N/A |
| EBIT Q2Q % growth | 14.692B -11.52% | 14.193B -16.39% | N/A | N/A | N/A |
All data in INR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2026 Q2Q % growth | 14.53 -14.29% | 13.88 | 0.65 | 4.69% |
| Q2 2026 Q2Q % growth | 16.18 7.44% | 17.69 | -1.51 | -8.52% |
| Q1 2026 Q2Q % growth | 17.03 1.94% | 18.26 | -1.23 | -6.74% |
| Q4 2025 Q2Q % growth | 19.12 21.89% | 18.60 | 0.52 | 2.77% |
| Q3 2025 Q2Q % growth | 16.95 2.28% | 17.52 | -0.57 | -3.24% |
| Q2 2025 Q2Q % growth | 15.06 -15.36% | 17.33 | -2.27 | -13.10% |
| Q1 2025 Q2Q % growth | 16.71 -1.04% | 15.66 | 1.05 | 6.71% |
| Q4 2024 Q2Q % growth | 15.68 35.84% | 14.96 | 0.72 | 4.81% |
| Q3 2024 Q2Q % growth | 16.58 10.77% | 15.10 | 1.48 | 9.80% |
| Q2 2024 Q2Q % growth | 17.80 32.74% | 14.80 | 3.00 | 20.25% |
| Q1 2024 Q2Q % growth | 16.89 18.00% | 12.40 | 4.48 | 36.15% |
| Q4 2023 Q2Q % growth | 11.55 889.37% | 9.80 | 1.74 | 17.78% |
| Q3 2023 Q2Q % growth | 14.96 75.99% | 13.22 | 1.75 | 13.23% |
| Q2 2023 Q2Q % growth | 13.41 12.29% | 9.64 | 3.77 | 39.15% |
| Q1 2023 Q2Q % growth | 14.31 108.18% | 7.78 | 6.53 | 84.05% |
| Q4 2022 Q2Q % growth | 1.17 -82.49% | 8.10 | -6.93 | -85.59% |
| Q3 2022 Q2Q % growth | 8.50 3,469.75% | 8.98 | -0.48 | -5.31% |
| Q2 2022 Q2Q % growth | 11.94 30.15% | 8.22 | 3.72 | 45.28% |
| Q1 2022 Q2Q % growth | 6.87 -1.49% | 8.05 | -1.18 | -14.61% |
| Q4 2021 Q2Q % growth | 6.66 -27.71% | 7.96 | -1.29 | -16.25% |
| Q3 2021 Q2Q % growth | 0.24 103.46% | 8.81 | -8.57 | -97.30% |
| Q2 2021 Q2Q % growth | 9.17 -30.37% | 7.45 | 1.72 | 23.09% |
| Q1 2021 Q2Q % growth | 6.98 -12.65% | 6.20 | 0.78 | 12.57% |
| Q4 2020 Q2Q % growth | 9.22 | 6.56 | 2.65 | 40.44% |
| Q3 2020 Q2Q % growth | -6.88 | 6.00 | -12.88 | -214.68% |
| Q2 2020 Q2Q % growth | 13.18 | 6.87 | 6.31 | 91.86% |
| Q1 2020 Q2Q % growth | 7.99 | 5.59 | 2.40 | 42.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2026 Q2Q % growth | 87.534B 4.44% | 85.484B | 2.05B | 2.40% |
| Q2 2026 Q2Q % growth | 88.283B 9.83% | 89.633B | -1.35B | -1.51% |
| Q1 2026 Q2Q % growth | 85.721B 11.38% | 89.177B | -3.456B | -3.88% |
| Q4 2025 Q2Q % growth | 85.284B 19.89% | 85.641B | -357M | -0.42% |
| Q3 2025 Q2Q % growth | 83.812B 15.81% | 82.986B | 826M | 1.00% |
| Q2 2025 Q2Q % growth | 80.382B 16.45% | 78.202B | 2.18B | 2.79% |
| Q1 2025 Q2Q % growth | 76.961B 13.88% | 74.271B | 2.69B | 3.62% |
| Q4 2024 Q2Q % growth | 71.138B 12.65% | 72.58B | -1.442B | -1.99% |
| Q3 2024 Q2Q % growth | 72.368B 6.58% | 70.667B | 1.701B | 2.41% |
| Q2 2024 Q2Q % growth | 69.026B 9.01% | 69.536B | -510M | -0.73% |
| Q1 2024 Q2Q % growth | 67.579B 29.14% | 66.455B | 1.124B | 1.69% |
| Q4 2023 Q2Q % growth | 63.152B 15.35% | 61.607B | 1.545B | 2.51% |
| Q3 2023 Q2Q % growth | 67.898B 27.19% | 62.062B | 5.836B | 9.40% |
| Q2 2023 Q2Q % growth | 63.318B 9.42% | 58.494B | 4.824B | 8.25% |
| Q1 2023 Q2Q % growth | 52.329B 5.82% | 54.772B | -2.443B | -4.46% |
| Q4 2022 Q2Q % growth | 54.749B 14.82% | 52.723B | 2.026B | 3.84% |
| Q3 2022 Q2Q % growth | 53.383B 8.02% | 55.205B | -1.822B | -3.30% |
| Q2 2022 Q2Q % growth | 57.869B 17.84% | 52.999B | 4.87B | 9.19% |
| Q1 2022 Q2Q % growth | 49.451B 11.72% | 52.74B | -3.289B | -6.24% |
| Q4 2021 Q2Q % growth | 47.682B 7.18% | 49.377B | -1.695B | -3.43% |
| Q3 2021 Q2Q % growth | 49.419B 12.39% | 51.608B | -2.189B | -4.24% |
| Q2 2021 Q2Q % growth | 49.109B 2.04% | 47.456B | 1.653B | 3.48% |
| Q1 2021 Q2Q % growth | 44.265B 14.73% | 42.656B | 1.609B | 3.77% |
| Q4 2020 Q2Q % growth | 44.489B | 43.094B | 1.395B | 3.24% |
| Q3 2020 Q2Q % growth | 43.971B | 43.062B | 909M | 2.11% |
| Q2 2020 Q2Q % growth | 48.128B | 43.273B | 4.855B | 11.22% |
| Q1 2020 Q2Q % growth | 38.582B | 40.815B | -2.233B | -5.47% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.02% | -3.66% | 0.02% | -0.74% |
| Revenue | -0.43% | -1.38% | 1.31% | 1.14% |